Kodiak Sciences to present Phase 3 wet AMD data for Zenkuda

Kodiak Sciences will present detailed one-year efficacy and safety data for its Zenkuda drug in wet AMD at AAO 2026 on Oct. 9, 2026. Both Zenkuda and tabirafusp-ted achieved vision outcomes comparable to aflibercept at year one.